[
  {
    "ts": null,
    "headline": "Goldman Sachs Maintains Sell on Humana, Lowers Price Target to $158",
    "summary": "Goldman Sachs  analyst Nathan Rich   maintains Humana (NYSE:HUM) with a Sell and lowers the price target from $215 to $158.",
    "url": "https://finnhub.io/api/news?id=2a0f58d7e7689b37bb60f40c8c9e8479d4f761ce16c2a7ae315623ef5450d928",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771336550,
      "headline": "Goldman Sachs Maintains Sell on Humana, Lowers Price Target to $158",
      "id": 139136241,
      "image": "",
      "related": "HUM",
      "source": "Benzinga",
      "summary": "Goldman Sachs  analyst Nathan Rich   maintains Humana (NYSE:HUM) with a Sell and lowers the price target from $215 to $158.",
      "url": "https://finnhub.io/api/news?id=2a0f58d7e7689b37bb60f40c8c9e8479d4f761ce16c2a7ae315623ef5450d928"
    }
  },
  {
    "ts": null,
    "headline": "Humana’s CenterWell buys primary care provider MaxHealth",
    "summary": "The addition of 82 owned and affiliated clinics in Florida comes as Humana doubles down on its primary care portfolio.",
    "url": "https://finnhub.io/api/news?id=c2931d4d52d65225bd6fbcda54dba765ac10d9947f41ea1e96a59d92fcba927b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771334951,
      "headline": "Humana’s CenterWell buys primary care provider MaxHealth",
      "id": 139126721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "The addition of 82 owned and affiliated clinics in Florida comes as Humana doubles down on its primary care portfolio.",
      "url": "https://finnhub.io/api/news?id=c2931d4d52d65225bd6fbcda54dba765ac10d9947f41ea1e96a59d92fcba927b"
    }
  },
  {
    "ts": null,
    "headline": "Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers",
    "summary": "Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to",
    "url": "https://finnhub.io/api/news?id=6bbb3e2aa9a811c94b262954436f98b3d7e68186786ea5e4e840004f3a8d4fe4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771333200,
      "headline": "Lifeward’s ReWalk™ Personal Exoskeleton Now Covered by Aetna, Coverage Expands to Include Three of the Largest Medicare Advantage Insurers",
      "id": 139122463,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "HUM",
      "source": "Yahoo",
      "summary": "Aetna joins Humana and United Healthcare in providing Medicare Advantage coverage for beneficiaries who meet medical necessity criteria for the ReWalk Personal Exoskeleton Together, these three national Medicare Advantage insurers represent approximately 16 million beneficiaries across the United States HUDSON, Mass. and YOKNEAM ILLIT, Israel, Feb. 17, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology designed to",
      "url": "https://finnhub.io/api/news?id=6bbb3e2aa9a811c94b262954436f98b3d7e68186786ea5e4e840004f3a8d4fe4"
    }
  },
  {
    "ts": null,
    "headline": "Truist Securities Maintains Hold on Humana, Lowers Price Target to $200",
    "summary": "Truist Securities  analyst David Macdonald   maintains Humana (NYSE:HUM) with a Hold and lowers the price target from $285 to $200.",
    "url": "https://finnhub.io/api/news?id=7533209a4670f56f2d085b3483e7b45947976cf2a2be783f5b6c3d2c14be4ed4",
    "source": "Benzinga",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771329618,
      "headline": "Truist Securities Maintains Hold on Humana, Lowers Price Target to $200",
      "id": 139136242,
      "image": "",
      "related": "HUM",
      "source": "Benzinga",
      "summary": "Truist Securities  analyst David Macdonald   maintains Humana (NYSE:HUM) with a Hold and lowers the price target from $285 to $200.",
      "url": "https://finnhub.io/api/news?id=7533209a4670f56f2d085b3483e7b45947976cf2a2be783f5b6c3d2c14be4ed4"
    }
  },
  {
    "ts": null,
    "headline": "RBC Capital Downgrades Humana (HUM)",
    "summary": "RBC Capital Downgrades Humana (HUM)",
    "url": "https://finnhub.io/api/news?id=9bf9b9e2e9f3868ed7fc061e618037354cfb99708fcfc8cc15fdccccc8a0e484",
    "source": "Fintel",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1771299523,
      "headline": "RBC Capital Downgrades Humana (HUM)",
      "id": 139119098,
      "image": "",
      "related": "HUM",
      "source": "Fintel",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=9bf9b9e2e9f3868ed7fc061e618037354cfb99708fcfc8cc15fdccccc8a0e484"
    }
  }
]